Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction
Authors: Miyagi, Moriatsu1; Ishikawa, Yukio2; Mizuiri, Sonoo1; Aikawa, Atsushi1; Ohara, Takehiro1; Hasegawa, Akira1
Source: Clinical Transplantation, Volume 19, Number 4, August 2005 , pp. 456-465(10)
Publisher: Blackwell Publishing
Abstract:
Miyagi M, Ishikawa Y, Mizuiri S, Aikawa A, Ohara T, Hasegawa A. Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction. Clin Transplant 2005: 19: 456–465. © Blackwell Munksgaard, 2005 Abstract: To determine the significance of early subclinical rejection of renal allografts, we reviewed 127 biopsy specimens obtained soon after transplantation. Histological finding was categorized according to a modification of the Banff scheme as: acute rejection (AR), borderline changes (BL); non-specific inflammatory changes, (NI) and no rejection (NR). Subclinical rejection was defined as AR, BL or NI. Patients with BL or NI were divided into two groups; one was treated with high-dose methylprednisolone (MP), the other remained untreated. Freedom from chronic allograft dysfunction (defined as non-doubling of serum creatinine 5 yr after transplantation) was significantly more frequent in the NR group (89%) than in the BL (70%) and AR (64%) groups. At 1 yr after transplantation, mean serum creatinine had increased significantly only in the untreated group (p < 0.05), and re-biopsy showed that interstitial fibrosis had developed to a significantly greater extent in the untreated group than in the treated group (p < 0.01). Subclinical rejection in the early protocol biopsies correlated closely with subsequent allograft dysfunction. High-dose MP treatment for early subclinical rejection may be effective in suppressing the development of interstitial fibrosis at 1 yr after transplantation.Keywords: chronic allograft nephropathy; protocol biopsy; subclinical rejection
Document Type: Research article
DOI: 10.1111/j.1399-0012.2005.00303.x
Affiliations: 1: Department of Nephrology 2: Second Department of Pathology, Toho University, Tokyo, Japan

Click here for Page Help